|
Online CME Activity
A Closer Look at the ENHANCE Study
|
NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.
A Closer Look at the ENHANCE Study
1.00 AMA PRA Category 1 Credits™, 1.00 ANCC, 1.00 AANP
Learning Objective
Participants should be able to highlight the study design and methods of the study presented in this activity and discuss the applicability of the findings to clinical cardiology practice.
Accreditation
This educational program is conceived and credited in accordance with ACCME’s Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute’s Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.
| Credits |
Type |
Accreditation Statement |
Designation Statement |
| 1.00 |
AMA PRA Category 1 Credits™ |
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
Pri-Med Institute designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| 1.00 |
ANCC |
Pri-Med Institute is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. |
This activity for 1 contact hour is provided by Pri-Med Institute. |
| 1.00 |
AANP |
Pri-Med Institute is approved as a provider of nurse practitioner continuing education programs by the American Academy of Nurse Practitioners. AANP Provider number 040308. |
This program has been approved for 1 contact hour of continuing education, which includes 0.5 hours of pharmacology. |
Faculty and Editorial Board
Written By:
Jerome Cohen, MD, Professor of Internal Medicine, St. Louis University School of Medicine
Edited By:
Jean Baker, MS, RD
Financial Disclosure Statement(s)
Dr Cohen serves on the speakers bureau for Abbott Laboratories, King Pharmaceuticals, Inc and Novartis Corporation; and he serves as a consultant for Bayer HealthCare and Merck & Co, Inc.
Ms Baker has no financial relationships to disclose.
The content collaborators at Turnkey Solutions LLC reported the following: Emily A Bakerman RN, MS, C-ANP, Executive Vice President, has no relevant affiliations or financial relationships to disclose.
Commercial Support:
Merck/Schering-Plough Pharmaceuticals
Pri-Med Disclaimer
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or M|C Communications, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
|
|
|
